Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia
NCT01901575
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Tachycardia, Ventricular
Interventions
DRUG:
Remifentanil
Sponsor
NYU Langone Health